skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 130,342  for All Library Resources

Sorted by: Sorted by: TitleOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
021 Phenotype of the ACTC E99K transgenic mouse reproduces hypertrophic cardiomyopathy in patients
021 Phenotype of the ACTC E99K transgenic mouse reproduces hypertrophic cardiomyopathy in patients
Material Type:
Article 		Add to My Research

021 Phenotype of the ACTC E99K transgenic mouse reproduces hypertrophic cardiomyopathy in patients

Heart (British Cardiac Society), 2010-02, Vol.96 (4), p.e6-e7 [Peer Reviewed Journal]

2009, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2009 (c) 2009, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/hrt.2009.191064i

Full text available

Citations Cited by
2
02 Hydroxychloroquine myopathy: cardiac and skeletal muscle toxicity
02 Hydroxychloroquine myopathy: cardiac and skeletal muscle toxicity
Material Type:
Article 		Add to My Research

02 Hydroxychloroquine myopathy: cardiac and skeletal muscle toxicity

Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A1-A2 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.2

Full text available

Citations Cited by
3
068 The ventricular ectopic QS interval (VEQSI): diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
068 The ventricular ectopic QS interval (VEQSI): diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
Material Type:
Article 		Add to My Research

068 The ventricular ectopic QS interval (VEQSI): diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A39 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.68

Full text available

Citations Cited by
4
071 Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers
071 Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers
Material Type:
Article 		Add to My Research

071 Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A40-A41 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.71

Full text available

Citations Cited by
5
072 Fragmented QRS: a predictor of myocardial scar and fibrosis in hypertrophic cardiomyopathy
072 Fragmented QRS: a predictor of myocardial scar and fibrosis in hypertrophic cardiomyopathy
Material Type:
Article 		Add to My Research

072 Fragmented QRS: a predictor of myocardial scar and fibrosis in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A41-A41 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.72

Full text available

Citations Cited by
6
073 Evaluation of clinical markers of early disease expression and the ability to predict genotype in families with HCM and mutations in cardiac myosin binding protein C
073 Evaluation of clinical markers of early disease expression and the ability to predict genotype in families with HCM and mutations in cardiac myosin binding protein C
Material Type:
Article 		Add to My Research

073 Evaluation of clinical markers of early disease expression and the ability to predict genotype in families with HCM and mutations in cardiac myosin binding protein C

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A41-A42 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.73

Full text available

Citations Cited by
7
074 The prevalence and significance of left ventricular hypertrabeculation in highly trained athletes
074 The prevalence and significance of left ventricular hypertrabeculation in highly trained athletes
Material Type:
Article 		Add to My Research

074 The prevalence and significance of left ventricular hypertrabeculation in highly trained athletes

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A42-A42 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.74

Full text available

Citations Cited by
8
081 Acute derangement of cardiac energy metabolism and oxygenation during stress in hypertrophic cardiomyopathy—a potential mechanism for sudden cardiac death
081 Acute derangement of cardiac energy metabolism and oxygenation during stress in hypertrophic cardiomyopathy—a potential mechanism for sudden cardiac death
Material Type:
Article 		Add to My Research

081 Acute derangement of cardiac energy metabolism and oxygenation during stress in hypertrophic cardiomyopathy—a potential mechanism for sudden cardiac death

Heart (British Cardiac Society), 2012-05, Vol.98 (Suppl 1), p.A45-A46 [Peer Reviewed Journal]

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2012-301877b.81

Full text available

Citations Cited by
9
1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
Material Type:
Article 		Add to My Research

1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy

The Journal of clinical investigation, 2023-07, Vol.133 (14) [Peer Reviewed Journal]

COPYRIGHT 2023 American Society for Clinical Investigation ;2023 Zhuang et al. 2023 Zhuang et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI164660 ;PMID: 37200096

Full text available

Citations Cited by
10
1 H- and 31 P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes
1 H- and 31 P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes
Material Type:
Article 		Add to My Research

1 H- and 31 P-myocardial magnetic resonance spectroscopy in non-obstructive hypertrophic cardiomyopathy patients and competitive athletes

Radiologia medica, 2017-04, Vol.122 (4), p.265 [Peer Reviewed Journal]

EISSN: 1826-6983 ;PMID: 28070839

Digital Resources/Online E-Resources

Citations Cited by
11
1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis
1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis
Material Type:
Article 		Add to My Research

1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis

European journal of pharmacology, 2021-10, Vol.908, p.174309 [Peer Reviewed Journal]

Copyright © 2021 Elsevier B.V. All rights reserved. ;EISSN: 1879-0712 ;DOI: 10.1016/j.ejphar.2021.174309 ;PMID: 34252442

Digital Resources/Online E-Resources

Citations Cited by
12
1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis
1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis
Material Type:
Article 		Add to My Research

1-Methyl tryptophan, an indoleamine 2,3-dioxygenase inhibitor, attenuates cardiac and hepatic dysfunction in rats with biliary cirrhosis

Digital Resources/Online E-Resources

Citations Cited by
13
1-Week Withdrawal from 8 Weeks Alcohol Consumption Protects the Heart from Sepsis-Induced Dysfunction
1-Week Withdrawal from 8 Weeks Alcohol Consumption Protects the Heart from Sepsis-Induced Dysfunction
Material Type:
Article 		Add to My Research

1-Week Withdrawal from 8 Weeks Alcohol Consumption Protects the Heart from Sepsis-Induced Dysfunction

Alcoholism, clinical and experimental research, 1995-08, Vol.19 (4), p.834-839 [Peer Reviewed Journal]

1995 INIST-CNRS ;ISSN: 0145-6008 ;EISSN: 1530-0277 ;DOI: 10.1111/j.1530-0277.1995.tb00955.x ;PMID: 7485827 ;CODEN: ACRSDM

Full text available

Citations Cited by
14
1 Year) Cardiac Outcomes of Peripartum Cardiomyopathy
1 Year) Cardiac Outcomes of Peripartum Cardiomyopathy
Material Type:
Article 		Add to My Research

1 Year) Cardiac Outcomes of Peripartum Cardiomyopathy

The American journal of cardiology, 2023-05, Vol.194, p.71 [Peer Reviewed Journal]

2023. Elsevier Inc. ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2023.01.043

Full text available

Citations Cited by
15
1-year followup of cardiac status after adriamycin therapy
1-year followup of cardiac status after adriamycin therapy
Material Type:
Article 		Add to My Research

1-year followup of cardiac status after adriamycin therapy

Cancer treatment reports, 1979-11, Vol.63 (11-12), p.1809

ISSN: 0361-5960 ;PMID: 526915

Digital Resources/Online E-Resources

Citations Cited by
16
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study
Material Type:
Article 		Add to My Research

1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study

JACC. Cardiovascular interventions, 2023-11, Vol.16 (21), p.2600 [Peer Reviewed Journal]

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;EISSN: 1876-7605 ;DOI: 10.1016/j.jcin.2023.09.029 ;PMID: 37877913

Digital Resources/Online E-Resources

Citations Cited by
17
10 clinical trials to watch in the second half of 2022
10 clinical trials to watch in the second half of 2022
Material Type:
Article 		Add to My Research

10 clinical trials to watch in the second half of 2022

BioPharma Dive, 2022-07

Copyright Industry Dive Jul 5, 2022

Digital Resources/Online E-Resources

Citations Cited by
18
10 clinical trials to watch in the second half of 2023
10 clinical trials to watch in the second half of 2023
Material Type:
Article 		Add to My Research

10 clinical trials to watch in the second half of 2023

BioPharma Dive, 2023-06

Copyright Industry Dive Jun 28, 2023

Digital Resources/Online E-Resources

Citations Cited by
19
10-month follow-up of daily variations in diuresis in a case of chronic cardiomyopathy
10-month follow-up of daily variations in diuresis in a case of chronic cardiomyopathy
Material Type:
Article 		Add to My Research

10-month follow-up of daily variations in diuresis in a case of chronic cardiomyopathy

Srpski arhiv za celokupno lekarstvo, 1977-01, Vol.105 (1), p.57-70

ISSN: 0370-8179 ;EISSN: 2406-0895 ;PMID: 905876

Digital Resources/Online E-Resources

Citations Cited by
20
1,000TH PATIENT TREATED WITH IMPELLA IN JAPAN
1,000TH PATIENT TREATED WITH IMPELLA IN JAPAN
Material Type:
Article 		Add to My Research

1,000TH PATIENT TREATED WITH IMPELLA IN JAPAN

Biotech Equipment Update, 2019-11, Vol.27 (11)

Copyright Worldwide Videotex Nov 1, 2019

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 130,342  for All Library Resources

Sorted by: Sorted by: TitleOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1961  (329)
  2. 1961 To 1976  (3,345)
  3. 1977 To 1992  (13,503)
  4. 1993 To 2009  (33,555)
  5. After 2009  (79,605)
  6. More options open sub menu

Language 

  1. English  (118,868)
  2. Japanese  (13,959)
  3. Russian  (2,074)
  4. German  (1,901)
  5. Portuguese  (1,554)
  6. French  (1,452)
  7. Spanish  (1,334)
  8. Chinese  (959)
  9. Italian  (789)
  10. Polish  (543)
  11. Czech  (170)
  12. Korean  (150)
  13. Turkish  (136)
  14. Hungarian  (119)
  15. Norwegian  (94)
  16. Croatian  (70)
  17. Slovak  (69)
  18. Dutch  (67)
  19. Danish  (66)
  20. Bulgarian  (63)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait